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A B S T R A C T
The direct vasodilatory and negative chronotropic effects of adenosine in humans are counter-
balanced by a reflex increase in sympathetic nerve traffic. A suggested mechanism for this
reflex includes peripheral chemoreceptor activation. We, therefore, assessed the contribution of
carotid chemoreceptors to sympatho-excitation by adenosine. Muscle sympathetic nerve activity
was recorded during adenosine infusion (140 µg · kg−1 · min−1 for 5 min) in five patients lacking
carotid chemoreceptors after bilateral carotid body tumour resection (one male and four female,
mean age 51 +− 11 years) and in six healthy controls (two male and four female, mean age
50 +− 7 years). Sympathetic responses to sodium nitroprusside injections were assessed to measure
baroreceptor-mediated sympathetic activation. In response to adenosine, controls showed no
change in blood pressure, an increase in heart rate (+ 48.2 +− 13.2 %; P< 0.003) and an increase in
sympathetic nerve activity (+ 195 +− 103 %; P< 0.022). In contrast, patients showed a decrease
in blood pressure (− 14.6 +− 4.9/− 17.6 +− 6.0 %; P< 0.05), an increase in heart rate (+ 25.3 +− 8.4 %;
P< 0.032) and no significant change in sympathetic activity. Adenosine-induced hypotension in
individual patients elicited less sympathetic activation than equihypotensive sodium nitroprusside
injections. In humans lacking carotid chemoreceptors, adenosine infusion elicits hypotension
due to the absence of significant sympatho-excitation. Chemoreceptor activation is essential
for counterbalancing the direct vasodilation by adenosine. In addition, blunting of the baroreflex
sympathetic response to adenosine-induced hypotension may indicate a direct sympatho-inhibitory
effect of adenosine.
INTRODUCTION
The clinical use of adenosine as a therapeutic agent in
supraventricular tachycardia [1] and as a diagnostic tool
in adenosine-thallium stress testing for cardiac ischaemia
[2] is based on its negative chrono- and dromo-tropic [3]
and vasodilatory [4] properties respectively. However, in
conscious healthy subjects, adenosine infusion results in a
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Abbreviations: BP, blood pressure; BCBR, bilateral carotid body resection; DBP, diastolic BP; HR, heart rate; LBNP, lower body
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dose-related increase in heart rate (HR) and respiration
without a change in mean arterial blood pressure (BP)
[5–7]. Hypotension and bradycardia are prevented by
an increase in sympathetic nerve activity in response
to adenosine [5,8]. This sympatho-excitation reflex to
vasodilation is responsible for the absence of hypo-
tension and bradycardia, since, in patients with severe
autonomic failure and in anaesthetized subjects, in whom
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Table 1 Characteristics of individual BCBR patients
CBR, carotid body tumour resection. ∗According to surgical and pathological reports. nIX, ninth cranial nerve (glossopharyngeal nerve).
Parameters Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age (years) 44 58 44 62 36
Sex Female Female Female Female Male
First CBR
Time between surgery and investigation (years) 7.1 20.4 7.8 5.3 7.4
Side Right Left Left Left Left
Tumour size (max. cm)∗ 2.5 2.0 4.0 3.0 2.0
Radical resection∗ Yes No Yes Yes Yes
(Cranial) nerve damage∗ – – nIX – –
Second CBR
Time between surgery and investigation (years) 6.1 20.3 6.7 4.4 6.6
Side Left Right Right Right Right
Tumour size (max. cm)∗ 1.0 1.5 3.0 2.0 1.5
Radical resection∗ Yes No Yes No Yes
(Cranial) nerve damage∗ – Cervical plexus – – –
Symptoms/signs of baroreflex failure Persistent – – – Transient
Additional paraganglioma localizations/therapy – Right side skull basis/ – – –
radiotherapy
Family history of paraganglioma Yes Yes No Yes Yes
Medication Chloorthalidon, atenolol – – Atenolol –
and moxonidine
autonomic reflexes are blunted, adenosine produces
sustained hypotension [9,10].
Mechanisms that have been suggested to contribute
to a reflex increase in muscle sympathetic nerve activity
(MSNA) include activation of peripheral chemoreceptors
[7], unloading of arterial and cardiopulmonary baro-
receptors [8,11] and stimulation of adenosine-sensitive
afferent vessels in the heart [12], kidney [13] and forearm
[14]. Adenosine-induced activation of peripheral chemo-
receptors has beendemonstrated in animal studies [15,16].
Indirect evidence for the involvement of peripheral
chemoreceptors in the sympathetic activation by adeno-
sine in humans was provided by a differential effect
of adenosine on BP, which was dependent on the site of
infusion. Adenosine (with a very short half-life of < 1.5 s
[17]) has pressor effects when administered in the aortic
arch proximal to the origin of the carotid arteries, but
depressor effects when the carotid body chemoreceptors
are by-passed by administration at the level of the
descending aorta [7,18]. Furthermore, the MSNA and
HR responses to adenosine are blunted when peripheral
chemoreceptors are silenced by hyperoxia [11].However,
the relative impact of chemoreceptor activation on
sympatho-excitation by adenosine in humans remains to
be elucidated.
In a previous study [19], we have demonstrated
that carotid body chemoreflex function is abolished in
patients after removal of a bilateral carotid paraganglioma
[bilateral carotid body resection (BCBR)], as indicated
by the absence of a ventilatory response to normocapnic
hypoxaemia in these patients. The aim of the present
study was to examine the role of peripheral chemo-
receptors in the sympathetic activation by exogenous
adenosine by comparingMSNA responses to continuous
intravenous infusion of adenosine between BCBR
patients (lacking carotid chemoreceptors) and healthy
controls. In addition, MSNA responses to sodium nitro-




Five patients (one male and four females), who had
undergone BCBR at the Department of Otolaryngology,
University Medical Center Nijmegen, The Netherlands,
were included in this study. Individual information on
tumour size, additional tumour localizations and surgical
details of these five patients are shown in Table 1. The
median interval between the second operation and
the study was 6.7 years (range, 4.4–20.3 years). Patients
were free of diabetes, neurological, cardiovascular and
pulmonary disease. Six healthy subjects (two males and
four females) served as controls. Full medical history
and physical examination, including BP measurements,
revealed no abnormalities. Groups were matched for
age (51.2+− 10.8 years in BCBR patients compared with
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50.0+− 6.5 years in controls), body mass index (24.8+−
1.1 kg/m2 in patients compared with 25.7+− 3.8 kg/m2
in controls) and alcohol intake (7.8+− 8.5 units/week in
patients comparedwith 9.0+− 7.4 units/week in controls).
The study protocol was carried out in accordance with
the Declaration of Helsinki (2000) of the World Medical
Association and was approved by the Institutional Ethics
Committee. All subjects gave their informed consent.
The procedures followed were in accordance with Insti-
tutional guidelines.
BP, HR and breathing frequency
Investigations were carried out during the morning after
an overnight fast in a room with an ambient temperature
of 22–24 ◦C.Subjects abstained fromcaffeine, tea, alcohol,
chocolate and smoking for at least 24 h [20]. Office
systolic and diastolic BP (SBP/DBP) was determined
from the mean of three supine sphygmomanometric
measurements after 10 min of rest. Continuous finger
arterial BP was monitored by a Finapres device (model 5)
[21], and HR by surface ECG connected to a Hewlett
Packard 378341A monitor. Respiratory rate was moni-
tored by changes in inspiratory and expiratory air
temperature by means of a nose thermistor (Fysicon
Medical Technology). An intravenous line was placed in
an anticubital vein for adenosine infusion.
Sympathetic nerve recordings
Multi-unit microneurographic recordings of post-
ganglionicMSNAwereobtainedwith aunipolar tungsten
electrode inserted selectively into a muscle–nerve fascicle
of the right peroneal nerve posterior to the fibula head,
as originally described by Sundlo¨f and Wallin [22]. A
reference electrode was inserted subcutaneously 1–3 cm
from the recording electrode. Electrodes were connected
to a preamplifier with a gain of 1000 and an amplifier
with a gain that could be varied from 30–90 as required in
each subject. Amplification was constant throughout the
study in each subject. Neural activity was fed through a
bandpass filter with a bandwidth of 700–2000 Hz. The
filtered neurogram was routed through an amplitude
discriminator to a storage oscilloscope and a loudspeaker.
For recording and analysis, the filtered neurogram was
fed through a resistance-capacitance integrating network
(time constant 0.1 s) to obtain a mean voltage neurogram
of MSNA. Acceptable recordings met the following cri-
teria: spontaneous bursts of neural discharge synchro-
nous with HR, no response to arousal stimuli or skin
stroking and an increase in nerve burst frequency with
apnoea.
Study protocol
After instrumentation, subjects lay quietly for a period
of stabilization of 20 min. After a 5–10 min baseline
recording, adenosine (adenocor®; 6 mg in 2 ml) was
administered intravenously at a dosage of 140 µg ·kg−1 ·
min−1 during a 5 min period. This infusion rate is similar
to the dose that is applied during diagnostic myocardial
stress testing [23].
To assess the baroreflex control of sympathetic out-
flow, we calculated the increase in MSNA in response to
a decrease in BP induced by SNP [24]. After a 20 min
baseline period, graded bolus injections of SNP (12.5,
25, 50 and 100 µg) were given intravenously. The dosage
producing a decrease in arterial pressure of ≈ 15 mmHg
was repeated three times at intervals of 10 min.
Data analysis
A computer-assisted method was applied for automatic
detection and quantification of individual bursts of
sympathetic nerve activity by means of a curve-fitting
method. During a prescan of the tracing, the neurogram
was correlated with a triangular signal by applying a
least-squares algorithm. In order to define ‘reference
bursts’, the 100 largest triangular waves detected during
the prescan were taken. After discarding the 20 largest
waves for possible artefacts, the remaining 80 were taken
as a reference. Their mean amplitude and delay from the
corresponding R-wave on the ECG were determined.
During a subsequent scan, the individual amplitude and
time delay of all triangular waves were comparedwith the
mean amplitude and delay of the reference waves. Waves
were accepted and marked as sympathetic bursts on two
conditions: an amplitude of> 20% of the mean reference
amplitude and a time delay of < 200 ms beneath or
above the mean reference delay. Automatically calculated
burst amplitude correlated well (r> 0.9) with manual
burst detection during supine rest and adenosine infusion
(H. J. L.M. Timmers,G.A. Rongen and J.W.M. Lenders,
unpublished work). MSNAwas expressed as bursts/min,
bursts/100 beats, total integrated activity (TIA)/min,
TIA/100 beats and mean integrated activity/burst.
Responses to adenosine infusion were expressed as
relative changes in BP, HR, breathing frequency and
MSNA, calculated as 1 min averages during the 5 min
of adenosine infusion and 5 min of recovery compared
with 1 min at baseline.
The relative increase in MSNA during a 20 s stable BP
minimum after SNP injection was taken as an estimate
of baroreflex control of sympathetic outflow during
sustained hypotension. In subjects that exhibited a hypo-
tension in response to adenosine, the relative increase
in MSNA was compared with the increase in MSNA
elicited by an equihypotensive dose of SNP in that
particular patient. For comparison of MSNA responses
to adenosine- and SNP-induced hypotension,we selected
a 1 min interval during adenosine infusion in which
the decrease in DBP was equal to the mean SNP-induced
decrease in BP. TheMSNA response to SNPwas taken as
the expected baroreflex-mediated sympathetic response
to hypotension during adenosine infusion [8].
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Statistics
Results are given as means+− S.E.M. unless indicated
otherwise. Differences between patients and controls
with respect to nominal variables were compared using
the χ 2 test. Other variables were compared using Stu-
dent’s t test or Mann–Whitney rank-sum test when
appropriate. A two-sided P< 0.05 was taken as the level
of significance. Statistical analysis was performed using
SPSS for Windows 6.1.3.
RESULTS
Sympathetic response(s) to adenosine
At baseline, sphygmomanometric SBP/DBP and HR
did not differ between groups (120.8+− 11.1/79.0+−
5.9 mmHg and 66.8+− 8.5 bpm in patients compared
with 123.3+− 11.9/81.5+− 7.6 mmHg and 66.2+− 6.5 bpm
in controls) and neither did sympathetic burst frequency
(39.6+− 20.0 bursts/min and 49.3+− 21.5 bursts/100 beats
in patients compared with 38.8+− 11.5 bursts/min, 59.0+−
19.8 bursts/100 beats in controls).
Patients and controls retrospectively reported the fol-
lowing symptoms during adenosine infusion: chest pain
(all patients and controls), dyspnoea (patients 1–3, con-
trols 1–4 and 6), flushing (patient 1), headache (patient 1),
nausea (patient 4 and control 5) and nervousness
(patient 1).
Representative tracings of BP, HR and MSNA re-
sponses to adenosine, as observed in control 4 and BCBR
patient 4, are depicted in Figure 1. Group-averaged
responses during the fifth minute of adenosine infusion
compared with baseline are shown in Figure 2. Controls
had no significant change in SBP/DBP (+ 1.1+− 2.6/
− 2.1+− 2.0%), but significant increases in HR (48.2+−
13.2%; P< 0.003), MSNA expressed as TIA/min
(195+− 103%; P< 0.022) and integrated activity/burst
(38.0+− 12.0%; P< 0.036). The increase in MSNA ex-
pressed as bursts/min (+ 96+− 48%), bursts/100 beats
(+ 39.6+− 38%) and TIA/100 beats (+ 113+− 79%) in
controls were not significant. BCBR patients showed
a significant decrease in SBP/DBP of − 14.6+− 4.9/
−17.6+− 6.0% (P< 0.05) and a significant increase in
HR of + 25.3+− 8.4% (P< 0.032), and non-significant
increases inMSNA of+ 63.1+− 30.8%TIA/min,+ 7.4+−
7.8% mean integrated activity/burst, + 50.6+− 27.5%
bursts/min, + 18.2+− 16.8% bursts/100 beats and
+ 27.5+− 19.3% TIA/100 beats. The responses differed
significantly between patients and controls with respect
to SBP (P< 0.04), DBP (P< 0.004) and mean amplitude/
burst (P< 0.021). There was a trend towards a smaller
increase in HR in patients compared with controls
(P< 0.094). After the infusion, changes in BP, HR and
MSNA returned to baseline in both groups within 3–
5 min. Mean respiratory rates during adenosine infusion
were not different from baseline in patients (14.4+− 4.4
Figure 1 Individual responses to adenosine infusion in a
representative control (left panel) and patient (right panel)
The data are presented as 1-min-averaged relative changes in DBP, SBP, HR and
MSNA (TIA) during (1–5 min, broken-lined box) and after (6–10 min) adenosine
infusion compared with baseline (−1–0 min). The neurogram of the last 10 s
before, the fifth minute during and the fifth min after infusion are displayed at
the bottom.
and 16.4+− 1.9/min respectively) or controls (13.8+−
2.6 and 14.3+− 2.2/min respectively).
Sympathetic response(s) to SNP
MSNA responses to SNP-induced hypotension com-
pared with changes in MSNA in the four BCBR patients
that exhibited a BP decrease during adenosine infusion
(patients 2–5) are shown in Figure 3. Adenosine elicited
smaller increases in MSNA than equihypotensive doses
of SNP.
DISCUSSION
In the present study, we have investigated the role of peri-
pheral chemoreceptors in the sympathetic activation by
exogenous adenosine by comparing MSNA responses to
continuous intravenous infusion of adenosine (140 µg ·
kg−1 ·min−1) between BCBR patients, lacking carotid
chemoreceptors, and healthy controls. Our principle
finding is that absence of carotid body chemoreflex func-
tion due to BCBR results in abolishment of significant
MSNA and HR responses to adenosine. In the absence
of chemoreceptor-dependent sympatho-excitation, aden-
osine infusion causes a 15%decrease in BP. Furthermore,
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Figure 2 Group-averaged responses to adenosine in patients and controls
Data are presented as relative mean+− S.E.M. changes from baseline in SBP, DBP, HR and MSNA (TIA) during the last min of adenosine infusion (t = 5 min) and after
return to baseline (t = 10 min). *Significant within-group change from baseline (P < 0.05), ¶significant difference in fifth min responses between controls and
patients.
the BP decrease induced by adenosine in BCBR patients
elicited a smaller increase in MSNA than expected from
the observed individual baroreflex-mediated MSNA
responses to SNP.
It has been well established [5–8], that continuous
adenosine infusion in healthy awake humans causes a
dose-dependent increase in HR, MSNA and plasma
noradrenaline levels without a change in mean arterial
BP. The tachycardic response correlates significantly
with increases in noradrenaline [5]. In a previous
study [25], spectral analysis of HR showed a reduced
parasympathetic and increased sympathetic influence on
the sinus node during intravenous infusion of adenosine
in healthy volunteers. Our present observations of
blunted MSNA and HR responses and hypotension in
response to adenosine infusion in patients lacking carotid
chemoreceptors indicate that carotid chemoreceptors are
indispensable in triggering autonomic reflexes during
adenosine infusion, which prevent hypotension that
would otherwise occur because of the direct vasodilatory
action of adenosine [26]. Evidence for peripheral chemo-
receptor activation by adenosine comes from animal
studies in which intracarotid infusion of adenosine causes
an A2-receptor-specific stimulation of afferent chemo-
receptor nerve traffic and ventilation [15,16]. In humans,
intravenous adenosine infusion produces a dose-related
increase in ventilation, due mostly to increased depth
of respiration [5,6] even at a dose below the threshold
for symptoms [7,27]. In line with these observations, we
found no effect of adenosine on respiratory rate in either
patients or controls. For practical reasons, we did not
perform spirometry during the infusion, so tidal volume
was not measured. Respiratory stimulation by adenosine
is suggested to result from peripheral chemoreflex acti-
vation, as ventilatory stimulation only occurs when
adenosine is injected proximal to the origin of carotid
arteries (and carotid chemoreceptors) and not after ad-
ministration in the descending aorta [7,18]. The finding
that adenosine increases the ventilatory response to
hypoxia, not to hypercapnia, reiterates its stimulatory
effect on peripheral chemoreceptors [27]. Previous stud-
ies [7,8,11,18] on the role of peripheral chemoreceptor
activation inmechanism of sympatho-excitation by aden-
osine infusion in humans have yielded merely indirect
C© 2004 The Biochemical Society
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Figure 3 Changes in MSNA in response to equihypotensive
doses of adenosine (closed bars) and SNP (open bars) in
individual patients
Relative changes in TIA/100 beats (upper panel) and TIA/min (lower panel) in
response to changes in DBP induced by adenosine and SNP. It should be noted
that, within each patient, adenosine and SNP induce similar decreases in DBP
(indicated at the bottom of the Figure) and that similar BP reductions elicit
smaller MSNA responses during adenosine infusion than during SNP infusion.
evidence. Adenosine was shown [7,18] to have a dif-
ferential pressor and depressor effect depending on infu-
sion proximal or distal to the carotid chemoreceptors
respectively. In addition, suppression of peripheral
chemoreceptors by hyperoxia was shown to decrease
MSNA and HR response to adenosine by one-third
compared with the normoxic response [11], and aden-
osine infusion causesHR andMSNA responses similar to
that observed during an equal ventilatory stimulation by
hypoxia [8].
We have reported previously [28] that BCBR has a
profound effect on peripheral chemoreflex function, as
suggested by the complete abolishment of the normo-
capnic ventilatory responsiveness to hypoxia. During
simultaneous hypercapnia, a small hypoxic response was
observed in two of eight patients (patients 4 and 5 in the
present study). This residual chemoreflex function was
attributed to the remaining aortic bodies. These subserve
aminor role in themodulationof spontaneous respiratory
activity in humans, but they may generate a discernible
responsewhen their gain is increased byhypercapnia [29].
Apart from carotid body chemoreceptor stimulation,
adenosine was shown to increase aortic chemoreceptor
discharge in cats [30]. However, blunted MSNA re-
sponses in BCBR patients suggest little, if any, contri-
bution of aortic chemoreceptors to the sympatho-
excitation by adenosine.
Other possible mechanisms for sympatho-excitation
by adenosine in humans, besides chemoreceptor acti-
vation, include stimulation of adenosine-sensitive affer-
ent vessels in the coronary arteries [12], kidney [13] and
forearm [14]. In addition, a reflex increase in MSNA
may be triggered by unloading of the arterial and cardio-
pulmonary baroreceptors by the direct vasodilator action
of adenosine [8,11]. In healthy subjects, adenosine was
shown to produce a greater increase in MSNA than
SNP injections at doses that resulted in equivalent hypo-
tension [8]. Arterial baroreceptor unloading, therefore,
does not completely explain the increase in sympathetic
traffic produced by adenosine. On the other hand, mech-
anical baroreceptor unloading by − 15 mmHg lower
body negative pressure (LBNP) elicited an MSNA re-
sponse similar to that observed during an equihypotens-
ive dose of adenosine [11]. However, this level of LBNP
causes both arterial and cardiopulmonary barorecep-
tor unloading, and the impact of LBNP and adenosine
on central venous pressure (and thereby on cardio-
pulmonary mechano-receptors) were not compared.
Adenosine was reported to cause no change [8], or even
a small increase [31], in central venous pressure, which
makes unloading of cardiopulmonary receptors unlikely.
Furthermore, caffeine abstinencewas lesswell implemen-
ted in the LBNP study [11], which may have undere-
stimated the autonomic response to adenosine [20].
In a previous study [28], we have shown that BCBR
results in attenuation of the baroreflex control of HR.
The decrease in baroreflex sensitivity after BCBR was
suggested to be due to partial denervation of the carotid
sinus baroreceptors. However, SNP-induced hypoten-
sion in these patients elicited a prominent baroreceptor-
mediated rise in MSNA, which was even larger than the
MSNA response to an equivalent decrease in BP during
adenosine infusion. We speculate that this finding is
explainedby an inhibitory role of adenosineonganglionic
neurotransmission [32]. Direct central depression of
sympathetic tone by exogenous adenosine [33] is unlikely
to occur, since adenosine crosses the blood–brain barrier
very slowly [34]. On the other hand, the sympathetic
nuclei lie close to the area postrema, which was shown
to be permeable to adenosine in animal studies [35].
In healthy awake individuals, this direct sympatholytic
effect of adenosine might be overwhelmed by the reflex
activation of sympathetic nerve traffic.
The findings of hypotension and absence of a signi-
ficant MSNA increase during adenosine infusion in
BCBR patients compared with the presence of a baro-
reflex-mediated MSNA response to SNP suggests that
neither baroreceptor unloading nor stimulation of adeno-
sine-sensitive afferents, other than carotid body chemo-
receptors, contribute significantly to the mechanism
of sympatho-excitation by intravenous adenosine.
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Interruption of the chemoreflex influence on sympathetic
outflow and unopposed direct vasodilatory action prob-
ably also accounts for adenosine-induced hypotension
during general anaesthesia [9]. The finding of an incidence
of hypotension (decrease in SBP − 30 mmHg) of 10%
(116 out of 1000) in patients undergoing adenosine-
thallium stress testing for cardiac ischaemia may be due
to the large prevalence of diabetes (25%) among these
patients [23].Diabetic autonomic neuropathymay cause a
disruption of the efferent sympathetic pathway by which
adenosine brings about reflex vasoconstriction. This may
also explain adenosine-induced hypotension in patients
with severe autonomic failure [7].
Conclusions
The present study indicates that carotid chemoreceptors
play a key role in the sympatho-excitation during intra-
venous adenosine infusion in humans. This chemo-
receptor-dependent increase in MSNA prevents
adenosine-induced hypotension by counterbalancing
its direct vasodilatory action. In addition, blunting of
the baroreflex-mediated MSNA response to adenosine-
induced hypotension may indicate a direct sympatho-
inhibitory effect of adenosine.
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